<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02916940</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-Diprophos-IPP</org_study_id>
    <nct_id>NCT02916940</nct_id>
  </id_info>
  <brief_title>Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.</brief_title>
  <official_title>Randomized Controlled Prospective Study on the Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers (Thumb Excluded).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brugmann University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is currently no real consensus on the optimal management of acute sprains of the
      proximal interphalangeal joint of the long fingers.

      The aim of this study is to assess the beneficial effect of an injection of corticosteroids
      for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute
      phase). This treatment, if effective, might become the treatment of choice for these types of
      injuries, instead of a prolonged immobilization or a careful early mobilization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flexion/extension deficit</measure>
    <time_frame>Baseline (day of kenacort injection)</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flexion/extension deficit</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flexion/extension deficit</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laxity in hyperextension</measure>
    <time_frame>Baseline (day of kenacort injection)</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laxity in hyperextension</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laxity in hyperextension</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Evaluation of the maximal amplitude of the articulation, as measured by a goniometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the articulation</measure>
    <time_frame>Baseline (day of kenacort injection)</time_frame>
    <description>Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the articulation</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the articulation</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prehension force</measure>
    <time_frame>Baseline (day of kenacort injection)</time_frame>
    <description>Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prehension force</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prehension force</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EVA scale</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Pain assessment at the level of the volar plate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EVA scale</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Pain assessment at the level of the volar plate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-DASH</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Assessment of the return to daily life activities or sport activities. Questionnaire of the Disabilities of the Arm, Shoulder and Hand.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-DASH</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Assessment of the return to daily life activities or sport activities. Questionnaire of the Disabilities of the Arm, Shoulder and Hand.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitchigan Hand Questionnaire</measure>
    <time_frame>7 days after injection</time_frame>
    <description>Auto-evaluation of the patient regarding the functionality of his/her articulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitchigan Hand Questionnaire</measure>
    <time_frame>30 days after injection</time_frame>
    <description>Auto-evaluation of the patient regarding the functionality of his/her articulation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sprain</condition>
  <arm_group>
    <arm_group_label>Diprophos</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients having had a sprain of the long fingers, within 2 weeks of consultation. This group will receive a single injection of corticoids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients having had a sprain of the long fingers (Eaton classification type I and II), within 2 weeks of consultation. This group will receive the standard of care treatment, without injection of corticoids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diprophos</intervention_name>
    <description>Single subcutaneous injection of Diprophos, in the acute phase.</description>
    <arm_group_label>Diprophos</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults over 18 years old

          -  Type I and II and III of the Eaton classification (except if fracture/luxation with
             more than 50% of the articular surface injured)

          -  Trauma of one articulation only

          -  Consultation within 2 weeks of trauma

        Exclusion Criteria:

          -  Patients under 18 years old and over 80 years old

          -  Pregnant/nursing women

          -  Eaton classification Type II with a fracture affecting more than 50% of the articular
             surface, or persistant instability after reduction.

          -  Open wounds, nerve lesion with sensitive issue and any wound needing a surgical
             intervention

          -  Underlying pathologies: rhumatological, neurological, congenital (giving
             hyperextensive articulations as a result)

          -  Corticoids allergy

          -  Infection within the treated zone

          -  Trauma antecedents at the level of the tendons.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nader Chahidi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinique du Parc LÃ©opold</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Place, MD</last_name>
    <email>laura.place@ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Albert De Mey, MD</last_name>
    <email>albert.demey@huderf.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Place, MD</last_name>
      <email>laura.place@ulb.ac.be</email>
    </contact>
    <investigator>
      <last_name>Laura Place, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert De Mey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc Leopold</name>
      <address>
        <city>Brussels</city>
        <zip>1040</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nader Chahidi, MD</last_name>
    </contact>
    <contact_backup>
      <phone>32 2 4345050</phone>
    </contact_backup>
    <investigator>
      <last_name>Nader Chahidi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Freiberg A, Pollard BA, Macdonald MR, Duncan MJ. Management of proximal interphalangeal joint injuries. J Trauma. 1999 Mar;46(3):523-8. Review.</citation>
    <PMID>10088864</PMID>
  </reference>
  <reference>
    <citation>Chalmer J, Blakeway M, Adams Z, Milan SJ. Conservative interventions for treating hyperextension injuries of the proximal interphalangeal joints of the fingers. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009030. doi: 10.1002/14651858.CD009030.pub2. Review.</citation>
    <PMID>23450596</PMID>
  </reference>
  <reference>
    <citation>Paschos NK, Abuhemoud K, Gantsos A, Mitsionis GI, Georgoulis AD. Management of proximal interphalangeal joint hyperextension injuries: a randomized controlled trial. J Hand Surg Am. 2014 Mar;39(3):449-54. doi: 10.1016/j.jhsa.2013.11.038. Epub 2014 Feb 4.</citation>
    <PMID>24503231</PMID>
  </reference>
  <reference>
    <citation>Micev AJ, Saucedo JM, Kalainov DM, Wang L, Ma M, Yaffe MA. Surgical Techniques for Correction of Traumatic Hyperextension Instability of the Proximal Interphalangeal Joint: A Biomechanical Study. J Hand Surg Am. 2015 Aug;40(8):1631-7. doi: 10.1016/j.jhsa.2015.05.011. Epub 2015 Jul 3.</citation>
    <PMID>26143967</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Socorro ORTIZ</investigator_full_name>
    <investigator_title>Head of clinic</investigator_title>
  </responsible_party>
  <keyword>sprains of the proximal interphalangeal joints of the long fingers</keyword>
  <keyword>Diprophos</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sprains and Strains</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone dipropionate, betamethasone sodium phosphate drug combination</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

